Pathological complete response as a surrogate for relapse-free survival in patients with triple negative breast cancer after neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pathological complete response as a surrogate for relapse-free survival in patients with triple negative breast cancer after neoadjuvant chemotherapy

Published:2016-05-14 Issue:11 Volume:8 Page:18399-18408
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Li JunJie¹²,Chen Sheng¹²,Chen CanMing¹²,Di GenHong¹²,Liu GuangYu¹²,Wu Jiong¹²,Shao ZhiMin¹²

Affiliation:

1. Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, Peoples Republic of China

2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, Peoples Republic of China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological Complete Response as Outcome Modifier in Breast Cancer Patients and Brain Metastasis;Indian Journal of Surgical Oncology;2024-02-20

2. ¿Está indicada la radioterapia o la radioquimioterapia primaria?;Revista de Senología y Patología Mamaria;2023-10

3. Preoperative Radio(Chemo)Therapy in Breast Cancer: Time to Switch the Perspective?;Current Oncology;2022-12-12

4. Stromal Tumor Infiltrating Lymphocytes (TIL) as a potential prognostic biomarker for recurrence in Locally Advanced Breast Cancer (LABC) patients;Bali Medical Journal;2022-11-21

5. Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible Combination;Cancers;2022-09-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP